New KP Variant Strains Trigger COVID Surge in India: No Increase in Severity

Two new COVID-19 strains, KP.1 and KP.2, derived from the JN1 Omicron variant, have caused a surge in cases in India. The rise in cases has not led to an increase in hospitalizations or severity. The government is actively monitoring the situation and has enhanced testing and genomic sequencing to manage the spread.

India is witnessing a surge in COVID-19 cases due to two highly transmissible strains, KP.1 and KP.2, the government informed Parliament. Derived from the JN1 Omicron variant, these strains have caused an increase in cases without amplifying hospitalizations or severe illness, according to data presented by Union Health Minister JP Nadda.

Maharashtra recorded the highest number of cases, followed by West Bengal and Uttarakhand. The strains predominantly trigger mild symptoms like fever, cold, and fatigue, with no associated rise in severe cases or hospitalizations so far. The government has taken several steps to address the situation, including enhancing healthcare infrastructure.

The National Centre for Disease Control (NCDC) underlined the importance of the Integrated Disease Surveillance Programme, operational in all states and Union territories for monitoring epidemic-prone diseases. Additionally, the Indian SARS-CoV-2 Genome Sequencing (INSACOG) network is conducting whole genomic sequencing to track emerging variants, bolstered by 67 labs and 400-plus sentinel sites nationwide.